Life under the CABOSUN: Cabozantinib improves quality‐adjusted survival in comparison with sunitinib
Sign Up to like & getrecommendations! Published in 2020 at "Cancer"
DOI: 10.1002/cncr.33168
Abstract: In the article by Chen et al that accompanies this editorial, a quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of the Cabozantinib Versus Sunitinib as Initial Targeted Therapy for Patients With Metastatic… read more here.
Keywords: quality; treatment; quality adjusted; cabozantinib ... See more keywords